NPS – Provides innovative tools for safe and rapid product release. Specifically designed for the challenges of ATMPs.
MycoFinder Real-Time PCR kit provides a sensitive, reliable, rapid and cost-effective solution for the quality control of Advanced Therapy Medicinal Products (ATMPs) and biopharmaceuticals.
It is fully compliant with EP 2.6.7, USP 63 and JP 17 - its simple innovative format reduces turnaround time and greatly eases sample preparation and handling.
Nissui Pharma Solutions is the European subsidiary of Nissui Pharmaceutical Co., Ltd Japan, incorporated in April 2019. NPS provides DNA extraction and PCR technologies for rapid, sensitive and cost-effective detection of mycoplasma in Advanced Therapy Medicinal Products (ATMPs) and biopharmaceuticals.
Nissui Pharmaceutical Co., Ltd. is a Japanese company supplying culture media, kits and instrumentation for medical diagnostics, life sciences and food and drink industries. Nissui Pharmaceutical, also, markets a range of over-the-counter pharmaceuticals and food supplements for pharmacies.
NPS will be attending the virtual Advanced Therapies Congress & Expo 2020. Come and discuss mycoplasma detection in ATMPs. We look forward to meeting you there....
Nissui Pharma Solutions (NPS) has successfully completed an EP validation study in partnership with Confarma, a Solvias group company, specialized in biological analysis. MycoFinder, a mycoplasma gene detection kit, fulfils all requirements for EP 2.6.7. This...
Nissui Pharmaceutical Solutions (NPS) has been created by Nissui Pharmaceutical (Japan) as their European product development, sales and marketing subsidiary. Headquartered in Paris, NPS will develop and market products across Europe as part of the international...